Menzel Garry E
Insider CIK 1556064 · RGLS COO & Executive VP, Finance · ADAP Director · STOK Director · BDTX Director · TCRR President and CEO, Director · DVA Senior Vice President, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | A Award deriv | 2026-06-26 | 2026-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2025-06-12 | 2025-06-12 | 30,550 | — | $0 | 30,550 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2025-06-03 | 2025-06-04 | 29,747 | — | $0 | 29,747 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-07-01 | 2024-07-01 | 1,121,604 | — | $0 | 1,121,604 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2024-06-06 | 2024-06-06 | 30,550 | — | $0 | 30,550 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 7,639 | — | $0 | 7,639 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-07-10 | 2023-07-10 | 47,702 | $0.91 | $43.4K | 75,056 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 2,158,776 | — | $0 | 2,158,776 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 736,548 | — | $0 | 736,548 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 1,251,966 | — | $0 | 1,251,966 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 359,700 | — | $0 | 359,700 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 3,568,026 | — | $0 | 3,568,026 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 57,846 | — | $0 | 57,846 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 2,715,816 | — | $0 | 2,715,816 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-03 | 2023-07-03 | 981,463 | — | $0 | 981,463 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 19,441 | — | $0 | 19,441 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 23,165 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 15,120 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 3,241 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 238,008 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 39,681 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 433,037 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 138,031 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 305,800 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer | 2023-06-01 | 2023-06-01 | 132,729 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer | 2023-06-01 | 2023-06-01 | 138,871 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer | 2023-06-01 | 2023-06-01 | 132,730 | — | $0 | 0 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award | 2023-06-01 | 2023-06-01 | 200,646 | — | $0 | 200,646 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award | 2023-06-01 | 2023-06-01 | 200,647 | — | $0 | 200,647 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award | 2023-06-01 | 2023-06-01 | 209,931 | — | $0 | 209,931 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2023-05-16 | 2023-05-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 39,681 | — | $0 | 39,681 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 238,008 | — | $0 | 238,008 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-13 | 2022-12-13 | 11,000 | $1.06 | $11.7K | 138,871 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-12 | 2022-12-13 | 10,613 | $1.10 | $11.7K | 149,871 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-09 | 2022-12-13 | 10,325 | $1.13 | $11.7K | 160,484 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-08 | 2022-12-09 | 9,314 | $1.25 | $11.6K | 170,809 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-07 | 2022-12-09 | 9,111 | $1.28 | $11.7K | 180,123 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-06 | 2022-12-07 | 14,886 | $1.35 | $20.1K | 189,234 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-05 | 2022-12-07 | 8,530 | $1.37 | $11.7K | 204,120 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2022-12-02 | 2022-12-05 | 8,408 | $1.39 | $11.7K | 212,650 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2022-12-01 | 2022-12-05 | 21,382 | — | $0 | 23,165 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2022-12-01 | 2022-12-05 | 40,881 | — | $0 | 15,120 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2022-12-01 | 2022-12-05 | 158,795 | — | $0 | 3,241 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise | 2022-12-01 | 2022-12-05 | 221,058 | — | $0 | 221,058 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 1,167 | — | $0 | 1,167 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 240,488 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 821 | — | $0 | 821 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 4,512 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 54,834 | — | $0 | 54,834 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 164,500 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 43,726 | — | $0 | 43,726 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 3,500 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 159,956 | — | $0 | 159,956 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 479,866 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-11-17 | 2022-11-18 | 2,080 | — | $0 | 2,080 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2022-11-17 | 2022-11-18 | 6,240 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | G Gift | 2022-07-05 | 2022-08-26 | 132,730 | — | $0 | 132,730 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | G Gift | 2022-07-05 | 2022-08-26 | 132,730 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | G Gift | 2022-07-05 | 2022-08-26 | 48,202 | — | $0 | 132,729 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | G Gift | 2022-07-05 | 2022-08-26 | 48,202 | — | $0 | 132,730 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | G Gift | 2022-07-05 | 2022-08-26 | 84,527 | — | $0 | 84,527 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | G Gift | 2022-07-05 | 2022-08-26 | 84,527 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2022-06-10 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-08 | 21,000 | — | $0 | 21,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2022-02-28 | 2022-03-18 | 1,425 | $2.30 | $3.3K | 180,932 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2021-12-10 | 2021-12-10 | 169,054 | $0.74 | $125.1K | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise deriv | 2021-12-10 | 2021-12-10 | 5,946 | $0.74 | $4.4K | 138,031 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-12-09 | 2021-12-10 | 305,800 | — | $0 | 305,800 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | M Exercise | 2021-12-09 | 2021-12-10 | 175,000 | $0.74 | $129.5K | 179,507 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2021-08-31 | 2021-12-10 | 422 | $14.26 | $6.0K | 4,507 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-25 | 11,650 | — | $0 | 11,650 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-04-20 | 2021-04-23 | 14,921 | — | $0 | 14,921 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2021-02-28 | 2021-03-08 | 686 | $16.12 | $11.1K | 4,085 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2020-12-10 | 2020-12-11 | 245,000 | — | $0 | 245,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2020-08-31 | 2021-03-08 | 1,132 | $10.10 | $11.4K | 3,399 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2020-08-13 | 2021-01-27 | 29,555 | — | $0 | 29,555 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2020-02-28 | 2020-03-27 | 1,287 | $10.10 | $13.0K | 2,267 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion deriv | 2020-02-03 | 2020-02-05 | 156,297 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion | 2020-02-03 | 2020-02-05 | 51,825 | — | $0 | 51,825 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-12-19 | 2019-12-20 | 168,000 | — | $0 | 168,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award | 2019-08-30 | 2020-03-27 | 980 | $12.75 | $12.5K | 980 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-04-11 | 2019-04-12 | 486,106 | — | $0 | 486,106 | SEC↗ |
| DVA DAVITA HEALTHCARE PARTNERS | A Award deriv | 2013-09-09 | 2013-09-11 | 120,000 | — | $0 | 120,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2012-12-11 | 2012-12-13 | 75,000 | — | $0 | 75,000 | SEC↗ |